- Access
- Grey market
- Cost / month
- ≈ €27–72
- researchers' estimate; no listing to price
Builds over days or weeks of regular use rather than with each dose.
r/Peptidesource· · 2 upvotesOriginal ↗
So far I've definitely seen a decrease in body fat and have slimmed down a lot in the trouble areas of the midsection. The first week there was about a week of mild headaches, but all has been good since then.
Positive150 mcg/day · Nasal · 1 month
portion control and 1.5-2 h training 5 days a week; also BPC-157/TB-500, ipamorelin and CJC-1295
r/Peptidesource· · 2 upvotesOriginal ↗
I’ve ran combos and frag before many times for different reasons with great results
PositiveInjection · several cycles, 8 weeks on / 8 off
alone and in combinations; reads like a sales pitch for the blend
r/Peptidesource· · 7 upvotesOriginal ↗
I am very active in the gym 4-5 lifting sessions with cardio after per week and I feel like I am gaining weight on my midsection as well as the scale. It's been about 1 month total
NegativeInjection · about 1 month
frag and hexarelin twice daily, BPC-157/TB-500, CJC-1295 with DAC, semaglutide 2.4 mg; lifting 4-5 times a week
- Users report
- Mixed and heavily confounded. About a third report fat loss or a better body composition, but every one of those was dieting hard or also on CJC-1295/ipamorelin, BPC-157, retatrutide or tirzepatide; the cleanest positive is a month of 150 mcg nasal frag with portion control and 1.5-2 h of daily training. Another third felt nothing and say real GH or a GLP-1 does far more. The rest are negatives: vials that gel or turn cloudy so they cannot be used, weight gain on a GH-peptide stack, and appetite returning on a frag/CJC/ipa blend. A week of mild headaches is the one side effect mentioned. Experienced users repeat that it is the same thing as AOD-9604, which lost to placebo. Felt nothing: 5 of 15 reports felt nothing; 4 more were negative.
- Best effects
- Fat loss in 'trouble areas' (confounded by diet and other drugs) · reported body-composition change on frag/CJC/ipamorelin blends
- Downsides
- No noticeable effect for many · vials gel or go cloudy after reconstitution · mild headaches in the first week (one report) · appetite and bloating on blends (one report)
- Watch
- No human data at all for the fragment; its safety record is borrowed from AOD-9604, which differs by one residue · Grey-market injectable: purity, sterility and aggregation (gelling) unverified; aggregated peptide raises immunogenicity concerns · Prohibited in sport at all times (WADA S2.2.3, named explicitly)
- Evidence
- Animal only — Rat and mouse work only (the bare 177-191 fragment was antilipogenic but not lipolytic in rat fat pads). The human trials belong to AOD-9604, the Tyr-modified analogue: six trials, about 900 people, placebo-like safety, no IGF-1 or glucose change and no weight loss.
- Caveat
- Read with the AOD-9604 entry: the two are one residue apart, and what is sold as 'Frag 176-191' usually carries AOD's tyrosine anyway. AOD's six human trials found it safe and ineffective, and nothing suggests the fragment would differ, but the bare fragment itself has never been given to people in a study. It does not bind the GH receptor or raise IGF-1 in animals, which is why it is not treated as a GH-axis drug.
- Typical use
- 250-500 mcg subq once or twice daily, fasted (often before cardio), in 4-8 week cycles; one nasal user took 150 mcg a day. Not worth it on current evidence.
- Getting it
- Research-peptide vendors in 2-5 mg vials, often blended with CJC-1295 and ipamorelin; a few take it nasally. Despite the name, most vendors list the sequence YLRIVQCRSVEGSCGF, with tyrosine where native GH has phenylalanine at position 176, which is the AOD-9604 sequence; the vial is usually the same molecule as AOD-9604. Reconstitutes poorly: many vials gel or cloud in bacteriostatic water, and vendors advise acetic acid.
- Stacked with
- CJC-1295 and ipamorelin: Sold as a three-way blend; the positive blend reports cannot separate frag from the GH secretagogues. · Retatrutide or tirzepatide: Added to break a GLP-1 stall; users who tried it say the GLP-1 does nearly all the work. · AOD-9604: Some stack both, which experienced users point out is the same peptide twice.